国际生物制品学杂志
國際生物製品學雜誌
국제생물제품학잡지
INTERNATIONAL JOURNAL OF BIOLOGICALS
2010年
1期
20-24
,共5页
脊髓灰质炎病毒疫苗,口服%疫苗衍生脊髓灰质炎病毒%病毒结构蛋白质类%突变
脊髓灰質炎病毒疫苗,口服%疫苗衍生脊髓灰質炎病毒%病毒結構蛋白質類%突變
척수회질염병독역묘,구복%역묘연생척수회질염병독%병독결구단백질류%돌변
Poliovirus vaccine%oral%Vaccine-derived poliovirus%Viral structural proteins%Mutation
脊髓灰质炎(脊灰)病毒有3个血清型.VP1是脊灰病毒衣壳蛋白之一,它有4个抗原决定簇,可以诱导中和抗体,具有血清型特异性.脊灰病毒由于其RNA依赖性RNA聚合酶缺乏严密的自我校正功能,在自身复制过程中精确性下降,因此,会产生很多点突变,出现一些VP1区核苷酸突变热点.口服脊灰减毒活疫苗(OPV)的应用,有效地控制了脊灰,但因OPV病毒在人体肠道内复制过程中发生碱基突变,导致其神经毒力回升,引起疫苗相关麻痹型脊灰和出现疫苗衍生脊灰病毒(VDPV),使全球多次发生循环VDPV事件,对消灭脊灰带来新的挑战.为此,有关学者建议停止使用OPV,改用脊灰灭活疫苗或两种疫苗相结合的序贯免疫程序.
脊髓灰質炎(脊灰)病毒有3箇血清型.VP1是脊灰病毒衣殼蛋白之一,它有4箇抗原決定簇,可以誘導中和抗體,具有血清型特異性.脊灰病毒由于其RNA依賴性RNA聚閤酶缺乏嚴密的自我校正功能,在自身複製過程中精確性下降,因此,會產生很多點突變,齣現一些VP1區覈苷痠突變熱點.口服脊灰減毒活疫苗(OPV)的應用,有效地控製瞭脊灰,但因OPV病毒在人體腸道內複製過程中髮生堿基突變,導緻其神經毒力迴升,引起疫苗相關痳痺型脊灰和齣現疫苗衍生脊灰病毒(VDPV),使全毬多次髮生循環VDPV事件,對消滅脊灰帶來新的挑戰.為此,有關學者建議停止使用OPV,改用脊灰滅活疫苗或兩種疫苗相結閤的序貫免疫程序.
척수회질염(척회)병독유3개혈청형.VP1시척회병독의각단백지일,타유4개항원결정족,가이유도중화항체,구유혈청형특이성.척회병독유우기RNA의뢰성RNA취합매결핍엄밀적자아교정공능,재자신복제과정중정학성하강,인차,회산생흔다점돌변,출현일사VP1구핵감산돌변열점.구복척회감독활역묘(OPV)적응용,유효지공제료척회,단인OPV병독재인체장도내복제과정중발생감기돌변,도치기신경독력회승,인기역묘상관마비형척회화출현역묘연생척회병독(VDPV),사전구다차발생순배VDPV사건,대소멸척회대래신적도전.위차,유관학자건의정지사용OPV,개용척회멸활역묘혹량충역묘상결합적서관면역정서.
Polioviruses are classified into three serotypes.VP1 is one of the capsid proteins and has four epitopes which can stimulate neutralizing antibody to polioviruses.This capsid protein also determines the specificity of serotypes.Because the viral RNA polymerases generally lack self-proofreading mechanisms,polioviruses become one of the most rapidly evolving viruses and have several rapid variation sites in VP1 gene.With the routine immunization with oral poliovirus vaccine(OPV), the incidence of poliomyelitis has decreased dramatically.However, genetic variation may occur when the OPV viruses replicate in host's intestinal mucosa,resulting in reversion to neurovirulence of the polioviruses and leading to vaccine-associated paralytic poliomyelitis and vaccine-derived poliovirus (VDPV).There have been several events of the circulating VDPV worldwide, which makes new challenge to polio eradication.Therefore, experts suggest an immunization programme of inactivated poliovirus vaccine (IPV) in stead of OPV, or adoption of sequential immunization with IPV and OPV.